# US 2021/0277043 A1 · Functionalization and purification of molecules by reversible group exchange

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277043 A1
- Document ID: US20210277043A1
- Status: Published application
- Kind: A1
- Application number: 17/330,853
- Filed: 2021-05-26
- Published: 2021-09-09
- Earliest claimed: 2011-08-05
- Assignees: Illumina, Inc.
- Applicants: Illumina, Inc.
- Inventors: Frank J. Steemers; Kevin L. Gunderson; Kerri York; Ryan Christopher Smith
- Web page: https://patentgrep.com/patent/US20210277043A1

## CPC

- C07H 1/06: Separation; Purification
- C07D 495/04: Ortho-condensed systems
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12Q 1/6811: Selection methods for production or design of target specific oligonucleotides or binding molecules
- C07H 1/00: Processes for the preparation of sugar derivatives
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Embodiments of the present disclosure include methods and compositions for functionalizing molecules, such as oligonucleotides, with functional groups, including polyhistidine tags useful in affinity methods. Some embodiments include methods for modifying and purifying complex mixtures of molecules by exchange of functional tags.

## Claims

### Claim 1

A method of making functionalized-oligonucleotides, comprising:
providing at least two sets of oligonucleotides, a first set of oligonucleotides comprising a 5′-phosphate and a 3′-terminal block, and a second set of oligonucleotides comprising a 5′-functional group, wherein the 5′-functional group is an aldehyde group or comprises a biotin moiety;
ligating an oligonucleotide from the first set of oligonucleotides with an oligonucleotide from the second set of oligonucleotides to form functionalized-oligonucleotides.

### Claim 2 (depends on 1)

The method of claim 1, wherein the 3′-terminal block is a dideoxynucleotide.

### Claim 3 (depends on 1)

The method of claim 1, wherein the oligonucleotide from the first set of oligonucleotides is ligated with an oligonucleotide from the second set of oligonucleotides by using T4 ligase.

### Claim 4 (depends on 1)

The method of claim 1, further comprising removing non functionalized-oligonucleotides by adding (1) and/or (2):
(1) an exonuclease that digests unreacted oligonucleotides from the first set of oligonucleotides by preferentially digesting 5′-phosphorylated oligonucleotides; and/or a
(2) an exonuclease that digests unreacted oligonucleotides from the second set of oligonucleotides.

### Claim 5 (depends on 4)

The method of claim 4, wherein the exonuclease of (1) is a lambda exonuclease.

### Claim 6 (depends on 4)

The method of claim 4, wherein the exonuclease of (2) is E. Coli exonuclease I.

### Claim 7 (depends on 4)

The method of claim 4, wherein any non-functionalized oligonucleotides that comprise a 5′—OH group can be phosphorylated with T4 polynucleotide kinase prior to adding the exonuclease of (1) and/or the exonuclease of (2).

### Claim 8 (depends on 1)

The method of claim 1, wherein the 5′-functional group of the second set of oligonucleotides comprises a biotin moiety.

### Claim 9 (depends on 1)

The method of claim 1, wherein the 5′-functional group of the second set of oligonucleotides comprises an aldehyde group.

### Claim 10 (depends on 9)

The method of claim 9, the method further comprising:
reacting the aldehyde group of the functionalized oligonucleotide with a bifunctional linking reagent comprising a hydrazine or amine moiety under conditions to form an imine bond between the functionalized-oligonucleotide and the bifunctional linking reagent, wherein the bifunctional linking reagent further comprises a functional tag; and
contacting oligonucleotides comprising the first functional tag with a first binding partner and separating the oligonucleotides bound to the first binding partner from the other reaction components in order to isolate oligonucleotides comprising the first functional tag.

### Claim 11 (depends on 10)

The method of claim 10, wherein the bifunctional linking reagent comprises a 6-hydrazinonicotinate acetone hydrazone moiety or derivative thereof.

### Claim 12 (depends on 10)

The method of claim 10, wherein the first functional tag is selected from the group consisting of polyhistidine, biotin, and glutathione-S-transferase.

### Claim 13 (depends on 10)

The method of claim 10, wherein the first binding partner is selected from the group consisting of nickel, avidin, streptavidin, and glutathione.

### Claim 14 (depends on 10)

The method of claim 10, the method further comprising:
performing an exchange reaction by exchanging the first functional tag of the oligonucleotides with a second functional tag by breaking the imine bond formed between the functionalized oligonucleotide and the bifunctional linking ligand and forming a new imine bond with an exchange reagent comprising a second functional tag; and
contacting oligonucleotides comprising the second functional tag with a seconding binding partner and separating the oligonucleotides bound to the second binding partner from the other reaction components in order to isolate oligonucleotides comprising the second functional tag.

### Claim 15 (depends on 14)

The method of claim 14, wherein the second functional tag is selected from the group consisting of polyhistidine, biotin, and glutathione-S-transferase.

### Claim 16 (depends on 14)

The method of claim 14, wherein the second binding partner is selected from the group consisting of nickel, avidin, streptavidin, and glutathione.

### Claim 17 (depends on 14)

The method of claim 14, wherein the first binding partner and the second binding partner are the same.

### Claim 18 (depends on 14)

The method of claim 14, wherein the first functional tab and the second functional tab are different.

### Claim 19 (depends on 18)

The method of claim 18, wherein the first functional tab is polyhistidine, and the second functional tag is biotin.
